The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

Source: [Decrypt](https://decrypt.co/381467/openai-buys-orchestra-bio-ai-agents-drug-development)

Sponsored